AMN — Stock Film
STOCK FILMSCENE 1/11AMN · $34.79
Stock Expert AI presents
AMN
AMN Healthcare Services, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
AMN Healthcare Services, Inc. A quick introduction.

On the stock market since 2001, it operates in the world of health and science. It has 2,968 employees. Now — the numbers.

on the stock market since 2001
2,968 employees
$730.3M market value
Revenue last year:
$0
The loss that same year:
$0
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

WHERE DOES THE MONEY COME FROM?
92%Locum Tenens Staffing
Locum Tenens Staffing 92%Permanent Placement 8%
92% of all revenue comes from a single line: Locum Tenens Staffing.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales have been shrinking.

An average decline of 9% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$4B
2021
$5.2B
2022
$3.8B
2023
$3B
2024
$2.7B
2025
In the vault right now:
$0
DEBT: $803.2M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
86
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
55
average

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
96
very strong

The price looks reasonable next to what the company earns.

GROWTH
47
weak

Clearly below the class average.

PRICE MOMENTUM
84
very strong

The stock has been running stronger than the market lately.

WORTH WATCHING

Growth: Sales growth trails the sector average.

THE FIVE-YEAR JOURNEY
A big climb, then a hard fall.

An investor who bought at the very peak is down 73% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Delivers on expectations

It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.

2
THE BRIGHT SIDE · 2/2
Executives are buying their own stock

Over the last 12 months, company executives reported 41 buys and 38 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/2
The losses continue

A loss of $95.7M against $2.7B in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
A
0 / 100 · MoonshotScore

On our five-subject report card, AMN sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: AMN has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film